cell lines that transiently produced FSD-inducible variant fibrinogen presented the fibrous (3.2-22.7 and 2.1-24.5%, respectively) and large granular (5.4-25.5 and 7.7-23.9%) forms of intracellular inclusion bodies. Seven CHO and HuH-7 cell lines that transiently produced FSD-non-inducible variant fibrinogen only exhibit the large granular form. These results demonstrate that transiently transfected variant fibrinogen-producing CHO cells and inclusion bodies of the fibrous form may be useful in non-invasive screening for FSD risk factors for FSD before its onset.
Introduction
Fibrinogen is a 340 kDa and hexameric plasma glycoprotein that is synthesized by hepatocytes and consists of a double set of three polypeptide chains, Aα, Bβ, and γ, which are coded by the FGA, FGB, and FGG genes, respectively [1, 2] . Circulating fibrinogen concentrations range between 1.8 and 3.5 g/L, and congenital fibrinogen disorders are characterized by functional and antigenic fibrinogen concentrations; patients with lower levels or under detection limit of functional and antigen fibrinogen are fibrinogen deficient (type I; afibrinogenemia as a homozygote and hypofibrinogenemia as a heterozygote), while those with lower levels of functional fibrinogen and a normal level of antigenic fibrinogen have dysfunctional fibrinogenemia (type II; a homozygote and heterozygote) [3] . Almost 200 genetic abnormalities in patients with afibrinogenemia or hypofibrinogenemia have been detected in all three genes and identified as missense, nonsense, or Abstract Fibrinogen storage disease (FSD) is a rare disorder that is characterized by the accumulation of fibrinogen in hepatocytes and induces liver injury. Six mutations in the γC domain (γG284R, γT314P, γD316N, the deletion of γG346-Q350, γG366S, and γR375W) have been identified for FSD. Our group previously established γ375W fibrinogen-producing Chinese hamster ovary (CHO) cells and observed aberrant large granular and fibrous forms of intracellular inclusion bodies. The aim of this study was to investigate whether fibrous intracellular inclusion bodies are specific to FSD-inducible variant fibrinogen. Thirteen expression vectors encoding the variant γ-chain were stably or transiently transfected into CHO cells expressing normal fibrinogen Aα-and Bβ-chains or HuH-7 cells, which were then immunofluorescently stained. Six CHO and HuH-7 frameshift mutations; splice-site abnormalities; or large deletions, as listed in the fibrinogen variant database (updated on 22/06/2016, http://site.geth.org/site/PratiquesProfessonnelles/Base-de-donnees-Fibrinogene/DatabaseEnglish-Version/Fibrinogen-variants-Database-_79_.html).
Patients with afibrinogenemia or hypofibrinogenemia exhibit bleeding, recurrent miscarriages, and peripartum hemorrhages [3] . Only six hypofibrinogenemic variants are located in the γC domain (γG284-γG375) and 14 families have been diagnosed with fibrinogen storage disease (FSD), which accumulates the variant fibrinogen within the endoplasmic reticulum (ER) of hepatocytes and induces liver injury. FSD associated with hypofibrinogenemia was initially reported in Italian patients with the γG284R variant [4] and another family with the same type of variant was recently identified in Germany [5] . Five more heterozygous γ-chain variant fibrinogen types have been found in the γC domain (γT314P [6] , the deletion of γG346-Q350 [7] , and γR375W [5, [8] [9] [10] [11] [12] [13] [14] , γD316N [15] and γG366S [15] ). γR375W is designated as the Aguadilla mutation and has been identified in eight families from seven racial origins [5, [8] [9] [10] [11] [12] [13] [14] . Variant protein-accumulating disease in hepatocytes and the induction of liver disease were originally reported for a homozygous deficiency of α1-antitrypsin (A1AT, G342 K, the so-called Z-mutation) [16] . Moreover, the molecular mechanisms by which the A1AT Z-mutation causes hepatocyte injuries have been studied extensively and showed increased ER retention as a conformational disease, the activation of ER-specific stress responses, up-regulated mitochondrial autophagy, or mitochondrial injury and apoptosis [16] [17] [18] . Therefore, the A1AT Z-mutation is also designated as a hepatic ER storage disease [16, 17] .
We previously established γ375W variant fibrinogenproducing Chinese hamster ovary (CHO) cells and compared them with wild-type fibrinogen-producing cells for the synthesis of variant fibrinogen and morphological characteristics. We found that γ375W-synthesizing CHO cells secreted less fibrinogen and possessed two types of aberrant intracellular inclusion bodies, the large granular (LG) and fibrous (F) forms using immunofluorescence. We subsequently demonstrated that these inclusion bodies were derived from the ER using confocal laser scanning microscopy and transmission electron microscopy [19] .
In this study, to examine whether variant fibrinogenproducing cells and the immunofluorescence method may be utilized in the non-invasive screening of FSD-inducible variant fibrinogen, we established and observed five other CHO cell lines producing FSD-inducible variant fibrinogen and seven CHO cell lines producing FSD-non-inducible variant fibrinogen.
Materials and methods

Preparation of mutant expression vectors
The fibrinogen γ chain expression vector pMLP-γ (γN) [20] was altered by oligonucleotide-directed mutagenesis using the QuikChange II Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA, USA) and five mutagenesis primer pairs (Supplement Table 1 ). The expression vectors for γ375W, γ313N, γ326A, γ326S, γ326Y, γ336I, γ341D, and γ345D were previously mutated and described [19, 21, 22] .
Establishment of stable CHO cell lines producing variant fibrinogen
The resultant expression vectors, γ284R, γ314P, γ316N, γ∆G346-Q350, γ366S, γ375W, and γN were co-transfected with the histidinol selection plasmid (pMSVhis) into CHO cells that expressed normal human fibrinogen Aα-and Bβ-chains (AαBβ-CHO cells) as described previously [23] and the cell lines were designated as γ284R Fbg-, γ314P Fbg-, γ316N Fbg-, γ∆G346-Q350 Fbg-, γ366S Fbg-, γ375W Fbg-, and γN Fbg-CHO. Stable transfectants designated as the γ313N Fbg-, γ326A Fbg-, γ326S Fbg-, γ326Y Fbg-, γ336I Fbg-, γ341D Fbg-, and γ345D Fbg-CHO cell lines were previously established and described [21, 22] .
Moreover, the expression vectors coding γ314P, γ316N, γ∆G346-Q350, γ375W, and γN were transfected alone or co-transfected with the fibrinogen Aα-chain (pMLP-Aα) or Bβ-chain expression vector (pMLP-Bβ) and neomycin selection plasmid (pRSVneo) as described above, and the established cell lines were designated as γ375W-, Aαγ375W-, and Bβγ375W-CHO, respectively (representative for γ375W).
Enzyme-linked immunosorbent assay and immunoblot analysis
Fibrinogen concentrations in the culture media or cell lysates of stable fibrinogen-synthesizing CHO cells were assessed by an enzyme-linked immunosorbent assay (ELISA), as described previously [24] .
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) under reducing conditions (10% polyacrylamide gel) and an immunoblot analysis were performed as described previously [25] . Briefly, immunoblots were developed with a rabbit anti-human fibrinogen antibody (DAKO, Carpinteria, CA, USA), horseradish peroxidase conjugated-goat anti-rabbit IgG antibody (Medical and Biological Laboratories, Nagoya, Japan), and enhanced chemiluminescence (ECL) detection reagent (Amersham Pharmacia Biotech, Buckinghamshire, UK).
Immunofluorescence staining
In immunofluorescence microscopy, cells grown to 80% confluence on cover glasses in a 60-mm culture dish were fixed with 4% paraformaldehyde and permeabilized with 0.2% Triton X-100 [19] . Variant fibrinogen-producing cells were incubated for 1 h with a 1:50 diluted fluorescein isothiocyanate (FITC)-labeled sheep polyclonal antifibrinogen antibody (Medical and Biological Laboratories) and then mounted with VECTASHIELD Hard-Set Mounting Medium (Funakoshi, Tokyo, Japan) [19] . Cells were observed using 0.8-µm-thick or 0.4-µm-thick optical sections by a confocal laser scanning microscope (LSM 510 META; Zeiss, Oberkochen, Germany) and scanned in 30 high-power fields (×40 objective area). The percentages of aberrant inclusion body-positive cells (number of inclusion body-positive cells/total number of fibrinogen-synthesizing cells × 100) was evaluated by counting 1000 cells for γN Fbg-cell lines and 500 cells for variant fibrinogen-synthesizing cell lines.
Transmission electron microscopy
In transmission electron microscopy, sample preparation was performed as described previously [19] . Specimens were observed on JEM-1230 (JEOL, Tokyo, Japan) and images were recorded at ×15,000 with an accelerating voltage of 80 kV.
Transient transfection to CHO and HuH-7 cells
One day before transfection, AαBβ-CHO cells and HuH-7 cells (derived from human hepatoma and kindly provided by the RIKEN BRC through the National Bio-Resource Project of the MEXT, Japan) [26] were seeded on 6-well dishes until they reached 60% confluence. Expression vectors were transfected into AαBβ-CHO cells or HuH-7 cells using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA), according to the manufacturer's instructions. Immunofluorescence staining was performed 4 days after transfection, as described above.
Statistical analysis
The significance of differences in fibrinogen concentrations between wild-type and variant fibrinogen-producing cells was examined using a one-way ANOVA (analysis of variance) and Turkey-Kramer tests. The significance of differences in aberrant inclusion bodies between FSD-inducible and FSD-non-inducible variant fibrinogens was assessed by the non-parametric Mann-Whitney U test. A difference was considered significant when the p value was <0.05.
Results
Synthesis and secretion of recombinant variant fibrinogens in CHO cells
Normal and variant fibrinogen-inducible FSD were expressed in CHO cells and 9-12 fibrinogen-synthesizing cell lines each were selected as described in the Materials and Methods. Fibrinogen concentrations in culture media and cell lysates were measured by ELISA. The results obtained are shown in Fig. 1a -c. In γN Fbg-CHO cells, the concentrations of fibrinogen were 0.83 ± 0.20 µg/mL (mean ± SD, n = 9) for culture media and 1.15 ± 0.38 µg/ mL for cell lysates, resulting in a culture medium to cell lysate ratio of 0.77 ± 0.22. Apart from γ316N Fbg-CHO cells, fibrinogen concentrations in the culture medium of the variant fibrinogen-synthesizing cell lines were significantly lower than that of γN Fbg-CHO cells (Fig. 1a) . On the other hand, fibrinogen concentrations in all variant cell lysates were higher than that in γN Fbg-CHO cells (Fig. 1b) . All variant medium/cell lysate fibrinogen ratios were markedly lower than that of γN Fbg-CHO cells: γ284R; 0.05 ± 0.01, γ314P; 0.08 ± 0.04, γ316N; 0.26 ± 0.05, γ∆346-350; 0.08 ± 0.05, γ366S; 0.03 ± 0.02, γ375W; 0.09 ± 0.02 (Fig. 1c) .
Fibrinogen staining for established stable variant CHO cells
To investigate whether the 'LG' and 'F' forms of aberrant intracellular inclusion bodies exist in CHO cells, direct immunofluorescence staining was performed as described in the "Materials and methods" (Fig. 1d, Supplement Figure 1) . Original CHO cells were used as a negative control and γN Fbg-CHO cells as a normal control. In fibrinogen variant-inducible FSD, γ314P Fbg-and γ∆G346-Q350 Fbg-CHO cells showed aberrant intracellular inclusion bodies, similar to γ375W Fbg-CHO cells [19] . Since characteristic long and straight needle-like inclusion bodies were observed in γ316N Fbg-CHO cells (Fig. 1d) , we classified these as the 'F' form. Briefly, on day 4 after the subculture, the proportion of each staining pattern ('LG' and 'F', Supplement Figure 1 ) was as follows: γ314P Fbg-CHO cells; 27.2% and 37.3%, γ316N Fbg-CHO cells; 8.4 and 72.1%, γ∆346-350 Fbg-CHO cells; 53.7 and 12.3%, γ375W Fbg-CHO cells; 50.5 and 40.0%, respectively (Fig. 1d) . On the other hand, γ284R Fbg-CHO cells (Fig. 1d) showed 8.4% of the 'LG' form and 0% of the 'F' form, while γ366S Fbg-CHO cells showed 17.7% of the 'LG' form and 0% of the 1 3 'F' form (Fig. 1d) . We immunofluorescently stained two other clones for γ284R and γ366S Fbg-CHO cells, but did not observe the 'F' form (Table 1) .
In the hypofibrinogenemic variants reported to not induce FSD [27] [28] [29] [30] [31] , γ326Y Fbg-, γ336I Fbg-, and γ341D Fbg-CHO cells had less than 1.0% of the 'LG' form and 0% of the 'F' form, whereas γ313N Fbg-, γ326A Fbg-, γ326S Fbg-, and γ345D Fbg-CHO cells had more than 8% of the 'LG' form: 14.3, 13.1, 23.0, and 8.6%, respectively, and 0% of the 'F' form (Fig. 2) . We only observed the 'LG' form for variant fibrinogen-synthesizing CHO cells not inducing FSD.
Transient transfection of variant γ-chains into CHO cells or HuH-7 cells
On day 4 after transfection, the proportions of the 'LG' and 'F' forms of inclusion bodies were as follows: γ314P Fbg-, γ316N Fbg-, γ∆346-350 Fbg-, and γ375W Fbg-CHO cells had 21.8 and 5.3, 5.4 and 35.6, 25.5 and 3.2, 15.5 and 22.7%, respectively (Fig. 3a) , and all values were lower than those obtained from stable transfectants. On the other hand, in γ284R Fbg-CHO cells, the 'LG' form was 9.4% and the 'F' form was 4.9%. In γ366S Fbg-CHO cells, the 'LG' form was 5.6% and the 'F' form was 4.6% (Fig. 3a) . We transfected transiently the variant γ-chain three times and the 'F' form was observed at 3.4 ± 1.8% in γ284R Fbg-CHO cells and at 3.1 ± 1.4% in γ366S Fbg-CHO cells (Table 1) .
Since we speculated that the lower percentage of the 'F' form in γ284R Fbg-and γ366S Fbg-CHO cells may be caused by CHO cells that were non-hepatic and non-human cells, we performed the transient transfection of the variant γ-chain into the human hepatocyte cell line, HuH-7. Normal fibrinogen-producing cells, γN Fbg-HuH-7 cells, were stained in a similar pattern to original HuH-7 cells, γ284R Fbg-, γ314P Fbg-, γ316N Fbg-, γ∆G346-Q350 Fbg-, γ366S Fbg-, and γ375W Fbg-HuH-7 cells that stained positive for the 'LG' and 'F' forms, similar to transiently transfected CHO cell lines (Fig. 3b) . We transfected transiently the variant γ-chain three times and the 'F' form was observed at 1.4 ± 0.6% in γ284R Fbg-HuH-7 cells and at 3.2 ± 0.5% in γ366S Fbg-HuH-7 cells (Table 1) .
Furthermore, we performed immunofluorescence staining for transient transfectants whose variant fibrinogen resulted in hypofibrinogenemia, but did not induce FSD (γ313N Fbg-, γ326A Fbg-, γ326S Fbg-, γ326Y Fbg-, γ336I Fbg-, γ341D Fbg-, and γ345D Fbg-HuH-7 cells). The staining patterns and positive percentages ('LG' form: 0.2-7.0% and 'F' form: 0%) of aberrant inclusion bodies were similar to those obtained from transiently transfected CHO cell lines ('LG' form: 0.4-8.1% and 'F' form: 0%) ( Table 2 and images not shown).
The percentages of the 'LG' and 'F' forms in CHO and HuH-7 cells stained by a fibrinogen antibody were summarized in Fig. 4 . Medians and interquartile ranges depending on distributions were shown using a Box and Whisker plot. The 'F' form was observed in all six FSD-inducible variants of transiently transfected CHO cells and HuH-7 cells, but was absent in two (γ284R Fbg and γ366S Fbg) out of six variants of stably transfected CHO cells. The 'F' form was not observed in FSD-non-inducible variants of stably or transiently transfected CHO cells or transiently transfected HuH-7 cells. Furthermore, the non-parametric Mann-Whitney U test revealed that the percentage of the 'LG' form was significantly higher in cells with FSDinducible variants than in those with FSD-non-inducible variants.
Transmission electron microscopy
To compare the aberrant structure of the ER in stably transfected γ375W Fbg-CHO cells, we performed transmission electron microscopic observations on five other stably transfected FSD-inducible variant cell lines of CHO cells. Images are shown in Fig. 5 . The 'LG' form observed by immunofluorescence showed enlarged vacuoles in the ER, the outer surface of which had ribosomes attached, Table 1 Reproducibility of aberrant inclusion bodies in γ284R and γ366S transfectants
LG scattered large granular form, F fibrous form
Stable CHO cells
Transient CHO cells Transient HuH-7 cells γ284R
LG (%) 6.6 ± 2.9 11.4 ± 5. LG', 'F', and normal forms were indicated under the photo while those in γ284R Fbg- (Fig. 5b ) and γ366S Fbg-CHO cell lines (Fig. 5c ) were similar to those observed in γ375W Fbg-CHO cells (Fig. 5d) . Furthermore, the 'F' form showed an expanded ER. The outer surface also had ribosomes attached and the lumen was filled with regularly structured fibular materials, while those in γ314P Fbg- (Fig. 5e ) and γ∆G346-Q350 Fbg-CHO cells (Fig. 5g) were similar to those observed in γ375W Fbg-CHO cells were used as a normal control. γ284R Fbg-(γ284R), γ314P Fbg-(γ314P), γ316N Fbg-(γ316N), γ∆G346-Q350 Fbg-(γ∆), γ366S Fbg-(γ366S), and γ375W Fbg-cells (γ375W) were shown.
LG scattered large granular form, F fibrous form. Scale bar 20 μm. The percentages of the 'LG', 'F', and normal forms were indicated under the photo Table 2 Frequency of aberrant inclusion bodies in FSD-noninducible transient transfectants
LG scattered large granular form, F fibrous form γ313N γ326A γ326S γ326Y γ336I γ341D γ345D
CHO cells
LG (%) 3. ( Fig. 5h) . However, the expanded ER in γ316N Fbg-CHO cells (Fig. 5f ) was markedly wider than that in γ375W Fbg-CHO cells (Fig. 5h ) and the lumen was packed with a larger number of regularly structured fibular materials (Fig. 5h) . These figures corresponded to a fingerprint-like pattern, as shown in the hepatocytic inclusion bodies of FSD patients by transmission electron microscopy [4, [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . γ-chain vector, we established variant CHO cell lines that only expressed the variant γ-chain (for example, designated as γ375W CHO cells), normal fibrinogen Aα plus the variant γ-chain (for example, designated as Aαγ375W CHO cells), or Bβ plus the variant γ-chain (for example, designated as Bβγ375W CHO cells), and compared them with γ375W Fbg-CHO cells. SDS-PAGE and immunoblot analyses of cell lysates were performed under reducing conditions to confirm the synthesis of each peptide chain. Not only the γ-chain, but also the Aα-or Bβ-chain was observed in established CHO cell lines (Fig. 6a) . Although γ375W Fbg-CHO cells showed a large number of aberrant inclusion bodies including the 'F' form, not only γ375W CHO cells, but also Aαγ375W CHO cells and Bβγ375W CHO cells had no aberrant intracellular inclusion bodies of the 'LG' or 'F' form (Fig. 6b) . The same results were obtained for three other variant γ-chain vectors: γ314P, γ316N, and γ∆G346-Q350 (data not shown).
Discussion
The heterozygous variant fibrinogen, γR375W is known as fibrinogen Aguadilla and induces hypofibrinogenemia and FSD [5, [8] [9] [10] [11] [12] [13] [14] . We previously established recombinant γ375W stably producing CHO cells and observed the aberrant intracellular inclusion bodies, the 'LG' and 'F' forms, using an immunofluorescence method. Both inclusion bodies were identified as the ER by confocal microscopy and transmission electron microscopy [19] . Based on these results, we investigated whether variant fibrinogen-producing cells and the immunofluorescence method may be utilized in the screening of FSD-inducible variant fibrinogen. In this study, we established five other stably or transiently recombinant variant fibrinogens inducing FSD: γ284R [4, 5] , γ314P [6] , γ∆G346-Q350 [7] , γD316N [15] , and γG366S [15] , and seven recombinant variant fibrinogens inducing hypofibrinogenemia, but not FSD: γ313N [27] , γ326A [21] , γ326S [28] , γ326Y [29, 30] , γ336I [30] , γ341D [31] , and γ345D [30] . In the former FSD-inducible variant cell lines of CHO cells, all transient transfectants were positive for the 'LG' and 'F' forms. However, in the latter FSD-non-inducible variant cell lines of CHO cells, all transient transfectants were positive for the 'LG' form only. Therefore, the results obtained from immunofluorescence staining led us to the conclusion that the detection of the 'F' form in variant fibrinogen-synthesizing CHO cells may be specific to the FSD-inducible type of the LG scattered large granular form, F fibrous form, N nucleus, M mitochondria, ER endoplasmic reticulum hypofibrinogenemic variant. These results indicate that establishing variant fibrinogen transiently synthesizing CHO cells followed by immunostaining using a fibrinogen antibody has potential as a non-invasive screening method for the FSD-inducible type of the hypofibrinogenemic variant. However, difficulties are associated with explaining the difference between positivity for the 'F' form in transient transfectants of CHO cells and negativity in stable transfectants of CHO cells. Namely, the 'F' form was not detected in stable transfectants for γ284R Fbg-and γ366S Fbg-CHO cells, whereas we observed low percentages of the 'F' form in transient transfectants for γ284R Fbg-and γ366S Fbg-CHO cells.
It is of interest that human hepatocytes cell lines that natively produce fibrinogen, HuH-7 cells, are used as host cells for transfection. Since most FSD patients are heterozygotes for fibrinogen gene mutations, we hypothesize that the positive percentages of the 'LG' and/or 'F' forms for variant fibrinogen-synthesizing HuH-7 cells may be higher than those for variant fibrinogen-synthesizing xenogeneic and non-native cell lines, CHO cells. Therefore, we transiently transfected expression vectors into HuH-7 cells. Although these HuH-7 cells may produce homodimers of wild-type or variant fibrinogens and heterodimers of wild-type and variant fibrinogens and be analogous to the hepatocytes of heterozygous patients, the positive percentages of the 'LG' and/ Fig. 6 Establishment of four types of CHO cell lines expressing γ375W. Samples of CHO cell lysates were subjected to 10% SDS-PAGE under reducing conditions (a). Western blots were developed using an anti-fibrinogen antibody as described in the "Materials and methods". Established CHO cell lines were stained with a FITClabeled anti-fibrinogen antibody (b). CHO cell lines transfected with the γN expression vector were used as a normal control (lower panels). Only γ375W Fbg-CHO cells (upper panel, AαBβγ) showed the two aberrant inclusion bodies, 'LG'; the large granular form and 'F'; the fibrous form, while other cell lines, Aαγ375W (Aαγ), Bβγ375W (Bβγ), and γ375W (γ) CHO cells, stained positively for fine-granular forms and no aberrant inclusion bodies (upper panels). Scale bar 20 μm or 'F' forms of HuH-7 cells were similar to those of CHO cells. Since CHO cells grow faster than HuH-7 cells and are easier to maintain, we selected CHO cells in the screening of FSD-inducible variant fibrinogen.
The percentages of the 'F' form in transient transfectants were divided into two groups, namely higher (22.7 and 35.6%); γ375W and γ316N, and lower (4.9, 5.3, 3.2, and 4.6%); γ284R, γ314P, γ∆G346-Q350, and γ366S. These percentages of the 'F' form did not correlate with the synthesis, secretion, or medium/cell lysate fibrinogen ratios of variant fibrinogen stably expressed in CHO cells. Furthermore, the higher percentage of 'F' form-positive cells may not be related to liver functions or diseases or the age of onset [13] . These results suggest that genetic fibrinogen mutation carriers exhibit extreme variability in the severity of liver injury [13] . This variability indicates that the development of FSD is dependent not only on genetic fibrinogen mutations, but also additional environmental or genetic factors [13] . However, our procedure is useful for the screening of the FSD-inducible hypofibrinogenemic variant. On the other hand, the presence of the 'LG' form is difficult to interpret. Namely, the 'LG' forms from the FSD-inducible hypofibrinogenemic variant and FSD-non-inducible hypofibrinogenemic variant are the same or different, while that from the FSD-inducible hypofibrinogenemic variant may or may not transition to the 'F' form. Under our experimental conditions, double-positive CHO or HuH-7 cells with the 'LG' and 'F' forms were absent. We speculate that the presence of the 'LG' form reflects the reduced secretion of fibrinogen in transfected cells.
The molecular mechanisms by which variant fibrinogen induces FSD have not yet been elucidated; however, some hypotheses have been proposed; (1) mutant fibrinogen avoids the quality control ER-associated degradation pathway; namely FSD is one of the hepatic ER storage diseases demonstrated with the A1AT Z-mutation [16, 17] , (2) mutant fibrinogen avoids the autophagy degradation pathway [16, 18] , and (3) the fibrin-like conversion of fibrinogen occurs inside the ER. Electron microscopic examinations of biopsy samples of FSD livers revealed unique images, the so-called fingerprint pattern, namely a regular aggregation pattern of fibrinogen [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . Furthermore, we found that the ER lumen was filled with regularly structured fibular materials in γ314P, γ316N, γ∆G346-Q350, and γ375W Fbg-CHO cells and these appeared to have a fingerprint-like pattern, as shown in the hepatocytes of FSD patients. To clarify the third hypothesis, we analyzed the mechanisms underlying the formation of 'LG' and 'F' form inclusion bodies using γ314P, γ316N, γ∆G346-Q350, and γ375W vectors with several combinations of normal Aα-and/or Bβ-chain expression vectors. The results obtained revealed the aberrant intracellular inclusion bodies were formed solitary by the assembly of variant γ-chains into normal Aα-and Bβ-chains. In other words, the hexameric fibrinogen structure was crucial for the formation of the 'LG' and 'F' forms of inclusion bodies. However, our results did not clarify whether the fibrin-like conversion of fibrinogen occurred inside the ER.
Histological liver sections from A1AT Z-mutation [16] and FSD patients [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] show intracytoplasmic round eosinophilic inclusions surrounded by a clear halo; however, the former inclusions are more clearly visualized with the periodic acid-Schiff stain following a pretreatment with diastase (PASD), while the latter inclusions are negative on PASD staining. Therefore, immunostaining using specific antibodies is needed to differentiate the liver disorders caused by the A1AT Z-mutation and fibrinogen mutation. In addition, our preliminary experiment for CHO cells transfected with the plasmid containing cDNA with the A1AT Z-mutation only revealed the 'LG' form, namely none of the 'F' forms (data not shown). Accordingly, we speculate that the molecular mechanisms underlying the formation of inclusions and accumulation of variant proteins in hepatocytes may differ between the A1AT Z-mutation and fibrinogen mutation.
In conclusion, variant fibrinogen-producing cells and immunofluorescence staining are applicable as a non-invasive and useful procedure for screening for the presence or absence of principal risk factors for FSD-inducible variant fibrinogen before its onset. CHO cell lines transiently synthesizing variant fibrinogen showed the 'F' form specific for FSD more than stably synthesizing CHO cell lines. On the other hand, CHO cell lines stably synthesizing variant fibrinogen may be a useful tool for analyses of the molecular mechanisms responsible for the accumulation of fibrinogen and formation of the 'LG' and/or 'F' forms of inclusion bodies.
